SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-021627
Filing Date
2022-08-08
Accepted
2022-08-08 17:07:18
Documents
69
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q mrsn-20220630.htm   iXBRL 10-Q 1515354
2 EX-31.1 exhibit31110-qfy2022q2.htm EX-31.1 11204
3 EX-31.2 exhibit31210-qfy2022q2.htm EX-31.2 11168
4 EX-32.1 exhibit32110-qfy2022q2.htm EX-32.1 5797
  Complete submission text file 0001628280-22-021627.txt   6062121

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrsn-20220630.xsd EX-101.SCH 40104
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT mrsn-20220630_cal.xml EX-101.CAL 43804
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT mrsn-20220630_def.xml EX-101.DEF 203945
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrsn-20220630_lab.xml EX-101.LAB 505808
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrsn-20220630_pre.xml EX-101.PRE 349816
63 EXTRACTED XBRL INSTANCE DOCUMENT mrsn-20220630_htm.xml XML 848237
Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Filer) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38129 | Film No.: 221145316
SIC: 2834 Pharmaceutical Preparations